President Donald Trump issued an executive order banning federal funding and support for gender-affirming medical treatments for minors, citing concerns over long-term health effects. The order directs agencies to rescind existing policies and prohibit funding for medical institutions providing such care.
The Department of Health and Human Services must review scientific literature on gender dysphoria treatment, while the Department of Justice is tasked with investigating alleged consumer fraud related to such procedures. The order also bars TRICARE and federal employee health plans from covering gender-affirming care for minors.
Agencies must report on their progress within 60 days. The order is expected to face legal challenges from advocacy groups and Democratic-led states.